First Swiss deal with Iran via humanitarian channel has gone through - Swiss govt

SECO did not identify the Swiss drugmaker or give a value for the shipment, which it said involved a cancer drug used to treat iron overload caused by repeated blood transfusions. The pilot deal in January shipped to Iran cancer drugs and drugs required for organ transplants worth 2.3 million euros ($2.7 million).

A Swiss pharmaceutical company has completed the first transaction under a new humanitarian trade channel with Iran, the government in Bern said on Monday. The Swiss Humanitarian Trade Arrangement (SHTA) channel to bring food and medicine to Iran started trial operations in January, helping supply Swiss goods to the struggling population without tripping over U.S. sanctions.

"We would like to emphasize that the operationalization of the SHTA is progressing and that a number of companies have already been approved, more companies will follow. Further transactions should be carried out shortly," the State Secretariat for Economic Affairs (SECO) said by email. Food, medicine, and other humanitarian supplies are exempt from the sanctions that Washington reimposed on Tehran after President Donald Trump walked away from a 2015 international deal over Iran's nuclear program.

But the U.S. measures targeting everything from oil sales to shipping and financial activities have deterred several foreign banks from doing business with the Islamic Republic - including humanitarian deals. SECO did not identify the Swiss drugmaker or give a value for the shipment, which it said involved a cancer drug used to treat iron overload caused by repeated blood transfusions.

The pilot deal in January shipped to Iran cancer drugs and drugs required for organ transplants worth 2.3 million euros ($2.7 million). Geneva-based bank BCP and drugmaker Novartis took part in the pilot deal.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)